Although a cure is likely still a ways off, continuing to pursue long-acting injectable treatments and PrEP is key to reducing cases of HIV.
Antonio Urbina, MD
Advertisement
Medical Director for the Mount Sinai Institute for Advanced Medicine 7th Avenue clinic in New York City
Articles by Antonio Urbina, MD
Lenacapavir and cabotegravir are among the most important advancements in HIV prevention and treatment within the past 10 years.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on AJMC
1
CDC Officially Ends Hantavirus Response as Outbreak Risk Recedes
2
National HIV Testing Day Highlights Expanding PrEP, PEP Access, Persistent Barriers
3
Treatment Burden, End-of-Life Symptom Gaps in Multiple Myeloma
4
ATTR-CM Incidence, Prevalence Rose Sharply in the US
5